Vogl,NY on How to Ask Good Questions at Medical Meetings

Vogl, NY

S. Vogl

ASCO® 2024 Expert Recap: "Metastatic Breast Cancer Deep Dive & Clini…

2024 ASCO® Annual Meeting Insights Hub

S. Tolaney, H. Rugo

Clinical Applications of ctDNA in Breast Cancer Diagnosis and Manage…

University of Miami Sylvester Comprehensive Cancer Center

D. Tripathy

ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…

2024 ASCO® Annual Meeting Insights Hub

V. Subbiah

SABCS 2024 Noteworthy Abstracts in Early Breast Cancer

Sara Tolaney

H. Rugo

ACP 2024 Insights: Cancer of Unknown Primary

Insights from 2024 ACP Annual Meeting

S. Brondfield

ESMO 2024 Summary: The Emerging Global Epidemic of Early-Onset Cance…

2024 ESMO Annual Meeting Insights Hub

S. Ogino

Endocrine Adverse Events From Checkpoint Inhibitors

Yale Cancer Center

K. Herold

Visible vs. Invisible Cancers - The Genomics and Natural History

Laurence Klotz

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+ Sol…

UCSF School of Medicine

H. Kang

Managing Women's Health in Menopause: Evolving Approaches for the Ma…

PleXus Communications

J. Simon, T. Iyer, A. Fiffick, M. Minkin

History of Cancer and Its Treatment: What Will It Take to Cure?

University of Colorado Cancer Center

C. Lieu

ASCO® 2024 Summary: "Management of Higher Risk eBC Including BRCAm, …

2024 ASCO® Annual Meeting Insights Hub

M. Dolezal

2L Therapy for ER+ mBC Following CDK4/6i

James Martin

New Frontiers in Oncology: Advanced Diagnostics and Therapeutics

Springer Healthcare IME

S. Peters

The Future of Lung Cancer Care

Yale Cancer Center

M. Davies

Guiding Patients in End-Of-Life Preparation

Lydia Dugdale

Summary of the Updated Results of SOFT/TEXT Trials and the Meta-Anal…

PrecisCa

M. Pegram

ASCO® 2023 Insights: "ESR1 Mutational Landscape and Impact of Co-Exi…

Insights from 2023 ASCO® Annual Meeting

A. Medford

Understanding CRISPR and Gene Editing in the Treatment of Heme Malig…

UChicago Medicine

A. Cooper